These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 19202330

  • 1. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
    Potter K, Lenzo N, Eikelboom JW, Arnolda LF, Beer C, Hankey GJ.
    Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
    [Abstract] [Full Text] [Related]

  • 2. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
    Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF.
    BMC Cardiovasc Disord; 2008 Sep 20; 8():24. PubMed ID: 18803866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O.
    JAMA; 2008 Aug 20; 300(7):795-804. PubMed ID: 18714059
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
    Carlsson CM, Pharo LM, Aeschlimann SE, Mitchell C, Underbakke G, Stein JH.
    Am Heart J; 2004 Sep 20; 148(3):E11. PubMed ID: 15389247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
    Ho GY, Eikelboom JW, Hankey GJ, Wong CR, Tan SL, Chan JB, Chen CP.
    Stroke; 2006 Feb 20; 37(2):456-60. PubMed ID: 16397167
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M.
    JAMA; 2004 Feb 04; 291(5):565-75. PubMed ID: 14762035
    [Abstract] [Full Text] [Related]

  • 14. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT, Lena KB, Sali N, Syam S, Shenoy ST, Rajadhyaksha VD, Pai GP, Shaikh AA, Cardiovit Study Team.
    Curr Med Res Opin; 2006 Apr 04; 22(4):641-8. PubMed ID: 16684424
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.
    Saudi J Kidney Dis Transpl; 2009 Sep 04; 20(5):779-88. PubMed ID: 19736473
    [Abstract] [Full Text] [Related]

  • 16. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R.
    JAMA; 2010 Jun 23; 303(24):2486-94. PubMed ID: 20571015
    [Abstract] [Full Text] [Related]

  • 17. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø, Semb AG, Grundt H, Nordrehaug JE, Vollset SE, Ueland PM, Nilsen DW, Bakken AM, Refsum H, Nygård OK.
    J Intern Med; 2007 Aug 23; 262(2):244-53. PubMed ID: 17645592
    [Abstract] [Full Text] [Related]

  • 18. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ, Skeaff CM, McMahon JA, Venn BJ, Williams SM, Devlin AM, Innis SM.
    Br J Nutr; 2010 Jun 23; 103(11):1629-34. PubMed ID: 20089204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
    Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E, Heart Outcomes Prevention Evaluation 2 Investigators.
    Stroke; 2009 Apr 23; 40(4):1365-72. PubMed ID: 19228852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.